Literature DB >> 19807076

New syntheses of E7389 C14-C35 and halichondrin C14-C38 building blocks: double-inversion approach.

Dae-Shik Kim1, Cheng-Guo Dong, Joseph T Kim, Haibing Guo, Jian Huang, Paolo S Tiseni, Yoshito Kishi.   

Abstract

With sequential use of catalytic asymmetric Cr-mediated coupling reactions, E7389 C14-C35 and halichondrin C14-C38 building blocks have been stereoselectively synthesized. The C19-C20 bond is first formed via the catalytic asymmetric Ni/Cr-mediated coupling, i.e., 8 + 9 --> 10 (90%; dr = 22:1), in which vinyl iodide 8 is used as the limiting substrate. The C23-C24 bond is then formed via the catalytic asymmetric Co/Cr-mediated coupling, i.e., 13 + 14 --> 4 (82%; dr = 22:1), in which the alkyl-iodide bond in 14 is selectively activated over the vinyl-iodide bond. The catalytic asymmetric Ni/Cr-mediated reaction is employed to couple C14-C26 segment 19 with E7389 C27-C35 segment 20 (91%; dr = >55:1). In this synthesis, the C23-O bond is stereoselectively constructed via a double-inversion process, i.e., 21 --> 22, to furnish E7389 C14-C35 building block 22 in 84% yield. The same synthetic sequence has been employed to synthesize halichondrin C14-C38 building block 18b, i.e., 16a + 19 --> 18b.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19807076     DOI: 10.1021/ja9058475

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  7 in total

1.  Further Developments and Applications of Oxazoline-Containing Ligands in Asymmetric Catalysis.

Authors:  Robert Connon; Brendan Roche; Balaji V Rokade; Patrick J Guiry
Journal:  Chem Rev       Date:  2021-05-21       Impact factor: 60.622

2.  Bio-inspired synthesis and biological evaluation of a colchicine-related compound library.

Authors:  K C Nicolaou; Roman A Valiulin; Jonathan K Pokorski; Vicki Chang; Jason S Chen
Journal:  Bioorg Med Chem Lett       Date:  2012-04-07       Impact factor: 2.823

3.  Antitumor agents 281. Design, synthesis, and biological activity of substituted 4-amino-7,8,9,10-tetrahydro-2H-benzo[h]chromen-2-one analogs (ATBO) as potent in vitro anticancer agents.

Authors:  Yizhou Dong; Kyoko Nakagawa-Goto; Chin-Yu Lai; Susan L Morris-Natschke; Kenneth F Bastow; Kuo-Hsiung Lee
Journal:  Bioorg Med Chem Lett       Date:  2010-11-17       Impact factor: 2.823

4.  Dramatic improvement in catalyst loadings and molar ratios of coupling partners for Ni/Cr-mediated coupling reactions: heterobimetallic catalysts.

Authors:  Xiang Liu; James A Henderson; Takeo Sasaki; Yoshito Kishi
Journal:  J Am Chem Soc       Date:  2009-11-25       Impact factor: 15.419

5.  Chromium(II)-catalyzed enantioselective arylation of ketones.

Authors:  Gang Wang; Shutao Sun; Ying Mao; Zhiyu Xie; Lei Liu
Journal:  Beilstein J Org Chem       Date:  2016-12-19       Impact factor: 2.883

Review 6.  The Tetrahydrofuran Motif in Polyketide Marine Drugs.

Authors:  Laura Fernández-Peña; Carlos Díez-Poza; Paula González-Andrés; Asunción Barbero
Journal:  Mar Drugs       Date:  2022-02-03       Impact factor: 5.118

Review 7.  Capturing Biological Activity in Natural Product Fragments by Chemical Synthesis.

Authors:  Erika A Crane; Karl Gademann
Journal:  Angew Chem Int Ed Engl       Date:  2016-02-02       Impact factor: 15.336

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.